Pakistan Medical Association asks WHO to help resolve vaccine approval obstacles for travelers

A health worker prepares to inoculate a man with a dose of the Sinopharm Covid-19 coronavirus at a vaccination centre in Karachi, Pakistan, on May 23, 2021. (AFP)
Short Url
Updated 02 August 2021
Follow

Pakistan Medical Association asks WHO to help resolve vaccine approval obstacles for travelers

  • Asks that nations allow travelers to use any type of COVID-19 vaccines rather than limited brands
  • Says limiting approved list of jab manufacturers would hit travel and trade

KARACHI: The secretary general of the Pakistan Medical Association (PMA), Qaisar Sajjad, said the body had urged the World Health Organization (WHO) to help devise a policy making it mandatory for nations to allow travelers to be vaccinated with any brand of the COVID-19 vaccine, saying limiting the approved list of jab manufacturers would hit travel and trade.

Sajjad’s comments come after the PMA sent the WHO a letter highlighting concerns that a number of countries had made it mandatory for visitors to be vaccinated only with specific brands of COVID-19 shots.

“The concerned authorities of some countries have approved specific brands mandatory for incoming visitors,” the PMA wrote in a letter to WHO director-general Tedros Adhanom Ghebreyesus.

“We have approached the WHO because countries are using different brands of vaccines ... manufactured in different geographical locations, which means people are not being administered the same brand of vaccine globally," PMA’s Sajjad told Arab News.

Despite this, some countries have made it mandatory for visitors to be vaccinated by specific brands, which would have a "devastating" effect on international travel and trade.

“Keeping in view the above facts we request WHO to convince such countries to accept all vaccine brands approved by other countries for their citizens, otherwise it will create problems for people who wish to go abroad for employment, business, education, medical treatment and for other purposes,” Sajjad said.

Sajjad cited the example of Saudi Arabia, which had made the use of the Pfizer, AstraZeneca, Moderna, and Johnson and Johnson vaccines mandatory for all visitors to the kingdom, including for Hajj and Umrah pilgrims. Last week, Saudi health authorities added China's Sinopharm to its list of approved vaccines, bringing some relief to Pakistan where a government-run inoculation drive has - apart from limited AstaZena jabs - mostly used Chinese vaccines. 

Some of the most widely used vaccines around the world include Moderna, Pfizer, Sputnik, Oxford-AstraZeneca, Sinopharm, Sinovac, Covaxin,  Novavax, Johnson & Johnson, CornovaVac, and Covidecia.

Pakistan has so far vaccinated around five million people. 


Pakistan receives $1.2 billion from IMF under EFF, RSF loan programs— central bank

Updated 9 sec ago
Follow

Pakistan receives $1.2 billion from IMF under EFF, RSF loan programs— central bank

  • IMF Executive Board approved Pakistan’s second review under EFF, first review under RSF loan programs this week 
  • Disbursements from IMF have been crucial for cash-strapped Pakistan as it tries to recover from economic crisis 

ISLAMABAD: Pakistan’s central bank announced on Thursday that it has received $1.2 billion under the International Monetary Fund’s (IMF) External Fund Facility and Resilience and Sustainability Facility (RSF) loan programs. 

The IMF approved a $7 billion bailout package for Pakistan under its EFF program in September 2024 while in May 2025, it approved a separate $1.4 billion loan to Pakistan under its climate resilience fund. The RSF will support Pakistan’s efforts in building economic resilience to climate vulnerabilities and natural disasters. 

The global lender approved Pakistan’s second review under its $7 billion EFF program and first review under the RSF loan on Tuesday. As per the State Bank of Pakistan (SBP), the central bank received a combined sum of $1.2 billion under the EFF and RSF on Dec. 10. 

“The amount would be reflected in SBP’s foreign exchange reserves for the week ending on Dec. 12, 2025,” the SBP said in a statement. 

IMF bailouts have been crucial for cash-strapped Pakistan, which has been struggling with a prolonged economic crisis that has exhausted its financial reserves and weakened its currency. Pakistan came to the brink of a sovereign default in 2023 before a last-gasp IMF bailout package helped it avert the crisis. 

Pakistan has had to take tough decisions to comply with the IMF’s loan requirements, which include scrapping subsidies from food and fuel items to trigger inflation. Since then, Pakistan has attempted to regain stability by sharply reducing inflation and recording a current account surplus. 

The disbursement, however, comes at an important time for the South Asian country as it mitigates losses from a deadly monsoon season that killed over 1,000 people since late June and caused at least $2.9 billion in damages to agriculture and infrastructure.